Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of Donors of Solid Organs in relation to Infectious Diseases
Copyright © 2019 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved..
The immunosuppressive treatment that recipients receive from a solid organ transplantation hinders the defensive response to infection. Its transmission from the donor can cause dysfunction or loss of the graft and even death of the recipient if proper preventive measures are not established. This potential risk should be thoroughly evaluated to minimise the risk of infection transmission from donor to recipient, especially with organ transplantation from donors with infections, without increasing graft dysfunction and morbidity and mortality in the recipient. This document aims to review current knowledge about infection screening in potential donors and offer clinical and microbiological recommendations about the use of organs from donors with infection based on available scientific evidence.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
Enfermedades infecciosas y microbiologia clinica (English ed.) - 38(2020), 8 vom: 01. Okt., Seite 379-389 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Donación |
|---|
| Anmerkungen: |
Date Completed 23.08.2021 Date Revised 23.08.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.eimc.2019.10.016 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM304708992 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM304708992 | ||
| 003 | DE-627 | ||
| 005 | 20231225115550.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.eimc.2019.10.016 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1015.xml |
| 035 | |a (DE-627)NLM304708992 | ||
| 035 | |a (NLM)31870646 | ||
| 035 | |a (PII)S0213-005X(19)30316-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Len, Oscar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of Donors of Solid Organs in relation to Infectious Diseases |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.08.2021 | ||
| 500 | |a Date Revised 23.08.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2019 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved. | ||
| 520 | |a The immunosuppressive treatment that recipients receive from a solid organ transplantation hinders the defensive response to infection. Its transmission from the donor can cause dysfunction or loss of the graft and even death of the recipient if proper preventive measures are not established. This potential risk should be thoroughly evaluated to minimise the risk of infection transmission from donor to recipient, especially with organ transplantation from donors with infections, without increasing graft dysfunction and morbidity and mortality in the recipient. This document aims to review current knowledge about infection screening in potential donors and offer clinical and microbiological recommendations about the use of organs from donors with infection based on available scientific evidence | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Practice Guideline | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Donación | |
| 650 | 4 | |a Donation | |
| 650 | 4 | |a Infección | |
| 650 | 4 | |a Infection | |
| 650 | 4 | |a Solid organ transplantation | |
| 650 | 4 | |a Transmisión | |
| 650 | 4 | |a Transmission | |
| 650 | 4 | |a Trasplante de órgano sólido | |
| 700 | 1 | |a Los-Arcos, Ibai |e verfasserin |4 aut | |
| 700 | 1 | |a Aguado, José María |e verfasserin |4 aut | |
| 700 | 1 | |a Blanes, Marino |e verfasserin |4 aut | |
| 700 | 1 | |a Bodro, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Carratalà, Jordi |e verfasserin |4 aut | |
| 700 | 1 | |a Cordero, Elisa |e verfasserin |4 aut | |
| 700 | 1 | |a Fariñas, María Carmen |e verfasserin |4 aut | |
| 700 | 1 | |a Fernández-Ruiz, Mario |e verfasserin |4 aut | |
| 700 | 1 | |a Fortún, Jesús |e verfasserin |4 aut | |
| 700 | 1 | |a Gavaldà, Joan |e verfasserin |4 aut | |
| 700 | 1 | |a López-Medrano, Francisco |e verfasserin |4 aut | |
| 700 | 1 | |a López-Vélez, Rogelio |e verfasserin |4 aut | |
| 700 | 1 | |a Lumbreras, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Mahillo, Beatriz |e verfasserin |4 aut | |
| 700 | 1 | |a Marcos, María Ángeles |e verfasserin |4 aut | |
| 700 | 1 | |a Martin-Dávila, Pilar |e verfasserin |4 aut | |
| 700 | 1 | |a Montejo, José Miguel |e verfasserin |4 aut | |
| 700 | 1 | |a Moreno, Asunción |e verfasserin |4 aut | |
| 700 | 1 | |a Muñoz, Patricia |e verfasserin |4 aut | |
| 700 | 1 | |a Norman, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Pérez-Sáenz, José Luis |e verfasserin |4 aut | |
| 700 | 1 | |a Pumarola, Tomás |e verfasserin |4 aut | |
| 700 | 1 | |a Sabé, Núria |e verfasserin |4 aut | |
| 700 | 1 | |a San-Juan, Rafael |e verfasserin |4 aut | |
| 700 | 1 | |a Vidal, Elisa |e verfasserin |4 aut | |
| 700 | 1 | |a Domínguez-Gil, Beatriz |e verfasserin |4 aut | |
| 700 | 0 | |a Transplant Infection Study Group GESITRA of the Spanish Society of Infectious Diseases and Clinical Microbiology SEIMC the National Transplant Organization ONT |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Enfermedades infecciosas y microbiologia clinica (English ed.) |d 2012 |g 38(2020), 8 vom: 01. Okt., Seite 379-389 |w (DE-627)NLM220666776 |x 2529-993X |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2020 |g number:8 |g day:01 |g month:10 |g pages:379-389 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.eimc.2019.10.016 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2020 |e 8 |b 01 |c 10 |h 379-389 | ||